Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Medicines Company (The) (NASDAQ: MDCO).

Full DD Report for MDCO

You must become a subscriber to view this report.


Recent News from (NASDAQ: MDCO)

Alnylam Pharmaceuticals Tries To Rally The Troops With A Blizzard Of New R&D Candidates
There are two criticisms you’ll never read about Alnylam ( ALNY ) – that management is insufficiently promotional of the company, and that it doesn’t have enough pipeline candidates/ideas. Always a company with many irons in the fire, Alnylam hosted an R&D day Thursd...
Source: SeekingAlpha
Date: December, 08 2018 00:23
Notable earnings before Thursday's open
ACIW , AZN , BAM , CAH , CBB , CBM , CEVA , CHH , CNNE , CNP , COMM , COT , CRCM , CROX , DESP , DHI , DISCA , DNR , EBIX , ENDP , FLY , GCI , GPRE , GTT , HAIN , HII , HIMX , HL , HMHC , HRI , IMOS , JCI , KOP , LAMR , LAUR , LGND , LNG , LOXO , MDCO ...
Source: SeekingAlpha
Date: November, 07 2018 17:30
Report: Exploring Fundamental Drivers Behind SkyWest, Blueprint Medicines, HP, Hewlett Packard Enterprise, Cardinal Health, and The Medicines - New Horizons, Emerging Trends, and Upcoming Developments
NEW YORK, Nov. 05, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of SkyWest, Inc. (NASDAQ:SKYW), Blueprint Medicines Corporation (NASDAQ:BPMC...
Source: GlobeNewswire
Date: November, 05 2018 07:40
The Medicines Company to Announce Third-Quarter 2018 Financial Results on November 8
The Medicines Company (NASDAQ:MDCO) will host a conference call and audio webcast on Thursday, November 8, 2018, at 8:30 a.m., EST, to discuss its third-quarter 2018 financial results and operational developments. The conference call may be accessed by telephone as follows: U.S./Cana...
Source: Business Wire
Date: November, 01 2018 07:00
Tracking David Einhorn's Portfolio - Q2 2018 Update
This article is part of a series that provides an ongoing analysis of the changes made to David Einhorn's Greenlight Capital 13F portfolio on a quarterly basis. It is based on Einhorn's regulatory 13F Form filed on 08/14/2018. Please visit our Tracking David Einhorn's Greenlight Capital Hol...
Source: SeekingAlpha
Date: September, 02 2018 12:34

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-1434.3034.4435.0633.741,316,351
2018-02-2631.1031.4932.0330.1341,015,127
2018-02-2329.9731.0731.4229.321,386,556
2018-02-2231.4229.8332.0729.632,198,786
2018-02-2132.3031.6233.9631.361,959,496

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-17178,770291,74361.2765Short
2018-12-141,378,0431,884,74773.1155Short
2018-12-131,583,6472,133,77374.2182Short
2018-12-1279,417117,30167.7036Short
2018-12-11132,665376,52735.2339Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on MDCO.


About Medicines Company (The) (NASDAQ: MDCO)

Logo for Medicines Company (The) (NASDAQ: MDCO)

Not available

 

Contact Information

 

 

Current Management

  • Clive A. Meanwell / President, CEO
  • Peyton J. Marshall / CFO

Current Share Structure

  • Market Cap: $2,370,274,941 - 05/17/2018
  • Issue and Outstanding: 73,611,023 - 05/04/2018

 


Recent Filings from (NASDAQ: MDCO)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 28 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: August, 27 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 01 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: June, 11 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 06 2018
Specialized Disclosure Report
Filing Type: SDFiling Source: edgar
Filing Date: May, 30 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 09 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 30 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 25 2018

 

 


Daily Technical Chart for (NASDAQ: MDCO)

Daily Technical Chart for (NASDAQ: MDCO)


Stay tuned for daily updates and more on (NASDAQ: MDCO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: MDCO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in MDCO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of MDCO and does not buy, sell, or trade any shares of MDCO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/